GENETICALLY-DETERMINED FACTORS AS PREDICTORS OF RADIOLOGICAL CHANGE IN PATIENTS WITH EARLY SYMMETRICAL ARTHRITIS

被引:77
作者
EMERY, P
SALMON, M
BRADLEY, H
WORDSWORTH, P
TUNN, E
BACON, PA
WARING, R
机构
[1] UNIV BIRMINGHAM,DEPT BIOCHEM,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
[2] JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND
关键词
D O I
10.1136/bmj.305.6866.1387
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-To determine whether genetic factors associated with established rheumatoid arthritis could, in combination with rheumatoid factor, predict the development of radiological erosions in patients with early symmetrical (rheumatoid-like) arthritis. Design-Prospective study. Setting-Teaching hospital, early arthritis clinic. Subjects-Forty nine patients with symmetrical polyarthritis attending the early arthritis clinic. Main outcome measures-Conserved sequence of DRbeta third allelic hypervariable region, sulphoxidation capacity, rheumatoid factor, and development of radiologically determined bone erosions. Results-None of the 49 patients had radiological erosions at presentation but 25 developed these by four years. Patients with the conserved class II major histocompatibility complex (third allelic hypervariable of DRbeta1) genes associated with rheumatoid arthritis had a relative risk for the development of erosions of 1.9 (95% confidence interval 0.8 to 4.5). For poor sulphoxidation the risk was 2.5 (1.1 to 5.6) and for the presence of rheumatoid factor 1.8 (0.9 to 3.7). Of the 33 patients who had two or three of these risk factors, 24 developed erosions, with a relative risk of 11.6 (1.7 to 78.5) compared with only one of the 16 individuals with no or one risk factor. Conclusions-This preliminary study shows that by using these stable markers it is possible to make clinically useful predictions of outcome in patients with early symmetrical inflammatory arthritis.
引用
收藏
页码:1387 / 1389
页数:3
相关论文
共 13 条
  • [1] INCREASED PREVALENCE OF POOR SULFOXIDATION IN PATIENTS WITH RHEUMATOID-ARTHRITIS - EFFECT OF CHANGES IN THE ACUTE PHASE RESPONSE AND 2ND-LINE DRUG-TREATMENT
    EMERY, P
    BRADLEY, H
    GOUGH, A
    ARTHUR, V
    JUBB, R
    WARING, R
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1992, 51 (03) : 318 - 320
  • [2] EMERY P, 1984, J RHEUMATOL, V11, P626
  • [3] GARDINER M, 1989, STATISTICS CONFIDENC
  • [4] MOLECULAR DIVERSITY OF HLA-DR4 HAPLOTYPES
    GREGERSEN, PK
    MING, S
    SONG, QL
    MERRYMAN, P
    DEGAR, S
    SEKI, T
    MACCARI, J
    GOLDBERG, D
    MURPHY, H
    SCHWENZER, J
    CHANG, YW
    WINCHESTER, RJ
    NEPOM, GT
    SILVER, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (08) : 2642 - 2646
  • [5] Harris ED, 1989, TXB RHEUMATOLOGY
  • [6] GENETIC-ASPECTS OF THE POLYMODALLY DISTRIBUTED SULFOXIDATION OF S-CARBOXYMETHYL-L-CYSTEINE IN MAN
    MITCHELL, SC
    WARING, RH
    HALEY, CS
    IDLE, JR
    SMITH, RL
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (04) : 507 - 521
  • [7] VANDERHEIJDE DMF, 1988, SEMIN ARTHRITIS RHEU, V17, P284
  • [8] WILKENS RF, 1991, ARTHRITIS RHEUM, V34, P43
  • [9] THE MOLECULAR-BASIS OF SUSCEPTIBILITY TO RHEUMATOID-ARTHRITIS - THE CONFORMATIONAL EQUIVALENCE HYPOTHESIS
    WINCHESTER, RJ
    GREGERSEN, PK
    [J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1988, 10 (2-3): : 119 - 139
  • [10] HLA-DR4 SUBTYPE FREQUENCIES IN RHEUMATOID-ARTHRITIS INDICATE THAT DRB1 IS THE MAJOR SUSCEPTIBILITY LOCUS WITHIN THE HLA CLASS-II REGION
    WORDSWORTH, BP
    LANCHBURY, JSS
    SAKKAS, LI
    WELSH, KI
    PANAYI, GS
    BELL, JI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) : 10049 - 10053